Abilita Bio IncProfile last edited on: 7/31/2017
3210 Merryfield RowSan Diego, CA 92117
|
Business Identifier: NO Business Identifier is currently available for this company.
Public Profile:
Abilita Bio is a biotechnology company addressing enabling discovery and development of drugs targeting challenging membrane proteins, including G Protein-Coupled Receptors (GPCRs) and ion channels, including G Protein Coupled Receptors (GPCRs) and ion channels. The firm is currently incubating in JLabs San Diego - a life science innovation center operated by Janssen Research & Development. Abilita Bio has established research collaborations with global pharmaceutical companies to advance their internal drug discovery programs targeting GPCRs and ion channels and continues to extend the EMP™ platform into new applications through multiple risk-sharing collaborations with biotechnology industry partners, while leveraging the EMP™ platform to fuel a robust internal drug discovery pipeline focused on treating cancer and chronic pain.
Abilita Bio is a biotechnology company addressing enabling discovery and development of drugs targeting challenging membrane proteins, including G Protein-Coupled Receptors (GPCRs) and ion channels, including G Protein Coupled Receptors (GPCRs) and ion channels. The firm is currently incubating in JLabs San Diego - a life science innovation center operated by Janssen Research & Development. Abilita Bio has established research collaborations with global pharmaceutical companies to advance their internal drug discovery programs targeting GPCRs and ion channels and continues to extend the EMP™ platform into new applications through multiple risk-sharing collaborations with biotechnology industry partners, while leveraging the EMP™ platform to fuel a robust internal drug discovery pipeline focused on treating cancer and chronic pain.
|
||||||||||||||||||||||||||||||||||||||||||||
Smart Office Options
|
|
SBIR firms in the news
Processing...